Legend Biotech (LEGN) Misses Q1 EPS by 6c

Legend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $195.05 million versus the consensus estimate of $192.54 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• ROMA Green Finance signs $15M letter of intent for 5% stake in NXTGrid
• Crescent Biopharma (CBIO) Reiterated at Buy by Stifel on CR-003/SKB105 Potential